Poor performance of the rapid test for human brucellosis in health facilities in Kenya

PLoS Neglected Tropical Diseases

Volumn 11, Issue 4, 2017, Pages

  de Glanville, William A ^a,b,i   Conde Álvarez, Raquel ^c   Moriyón, Ignacio ^c   Njeru, John ^d,e   Díaz, Ramón ^c   Cook, Elizabeth A J ^a,b   Morin, Matilda ^f   Bronsvoort, Barend M de C ^g   Thomas, Lian F ^a,b   Kariuki, Samuel ^d   Fèvre, Eric M ^b,h  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

^c UNIVERSITY OF NAVARRA   (Spain)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^e FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^f UPPSALA UNIVERSITY   (Sweden)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF LIVERPOOL   (United Kingdom)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ROSE BENGAL I 131;

ADOLESCENT; ADULT; AGED; AGGLUTINATION TEST; ARTICLE; BRUCELLOSIS; CHILD; COOMBS TEST; DIAGNOSTIC ACCURACY; FEMALE; HEALTH CARE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; KENYA; LIVESTOCK; MALE; QUESTIONNAIRE; RAPID TEST; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEROLOGY; EVALUATION STUDY; FALSE POSITIVE RESULT; HEALTH CARE FACILITY; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; TIME FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRUCELLOSIS; CHILD; CHILD, PRESCHOOL; FALSE POSITIVE REACTIONS; FEMALE; HEALTH FACILITIES; HUMANS; KENYA; MALE; MIDDLE AGED; SEROLOGIC TESTS; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; YOUNG ADULT;

EID: 85019041778     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005508     Document Type: Article

References (67)

1. McDermott JJ, Arimi SM, Brucellosis in sub-Saharan Africa: epidemiology, control and impact. Vet Microbiol. 2002;90: 111–134. 12414138
2. McDermott J, Grace D, Zinsstag J, Economics of brucellosis impact and control in low-income countries. Rev Sci Tech. 2013;32: 249–261. 23837382
3. Godfroid J, Cloeckaert A, Liautard J-P, Kohler S, Fretin D, Walravens K, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36: 313–326. doi: 10.1051/vetres:2005003 15845228
4. Corbel MJ, Brucellosis: an overview. Emerging Infect Dis. 1997;3: 213–221. doi: 10.3201/eid0302.970219 9204307
5. Kadohira M, McDermott JJ, Shoukri MM, Kyule MN, Variations in the prevalence of antibody to brucella infection in cattle by farm, area and district in Kenya. Epidemiol Infect. Cambridge University Press; 1997;118: 35–41. 9042033
6. Muendo EN, Mbatha PM, Macharia J, Abdoel TH, Janszen PV, Pastoor R, et al. Infection of cattle in Kenya with Brucella abortus biovar 3 and Brucella melitensis biovar 1 genotypes. Trop Anim Health Prod. Springer Netherlands; 2012;44: 17–20. doi: 10.1007/s11250-011-9899-9 21660647
7. Philpott M, Auko O, Caprine brucellosis in Kenya. Br Vet J. 1972;128: 642–651. 4647703
8. Young EJ, An overview of human brucellosis. Clin Infect Dis. 1995;21: 283–290. 8562733
9. Franco MP, Mulder M, Gilman RH, Smits HL, Human brucellosis. Lancet Infect Dis. 2007;7: 775–786. doi: 10.1016/S1473-3099(07)70286-4 18045560
10. Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, Zinsstag J, Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis. 2012;6: e1929. doi: 10.1371/journal.pntd.0001929 23236528
11. Ariza J, Brucellosis: an update. The perspective from the Mediterranean basin. Reviews in Medical Microbiology. 1999;10: 125–135.
12. Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14: e469–78. doi: 10.1016/j.ijid.2009.06.031 19910232
13. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS Med. 2007;4: e317. doi: 10.1371/journal.pmed.0040317 18162038
14. Zinsstag J, Schelling E, Roth F, Bonfoh B, de Savigny D, Tanner M, Human benefits of animal interventions for zoonosis control. Emerging Infect Dis. 2007;13: 527–531. doi: 10.3201/eid1304.060381 17553265
15. Colmenero JD, Cabrera FP, Hernadez S, Reguera JM, Pinedo A, Clavero AMC, Repercusión socio-económica de la brucelosis humana. Rev Clinica Espanola. 1989;185: 55–63.
16. Corbel MJ, Brucellosis in Humans and Animals. WHO; 2006. pp. 1–90.
17. Ducrotoy M, Bertu WJ, Matope G, Cadmus S, Conde-Álvarez R, Gusi AM, et al. Brucellosis in Sub-Saharan Africa: Current challenges for management, diagnosis and control. Acta Trop. 2015.
18. Spink WW, The diagnosis of human brucellosis. The nature of brucellosis. The University of Minnesota Press; 1956. pp. 191–215.
19. Crump JA, Morrissey AB, Nicholson WL, Massung RF, Stoddard RA, Galloway RL, et al. Etiology of severe non-malaria febrile illness in Northern Tanzania: a prospective cohort study. PLoS Negl Trop Dis. 2013;7: e2324. doi: 10.1371/journal.pntd.0002324 23875053
20. Marcotty T, Matthys F, Godfroid J, Rigouts L, Ameni G, Gey van Pittius N, et al. Zoonotic tuberculosis and brucellosis in Africa: neglected zoonoses or minor public-health issues? The outcomes of a multi-disciplinary workshop. Ann Trop Med Parasitol. 2009;103: 401–411. doi: 10.1179/136485909X451771 19583911
21. Omer MK, Assefaw T, Skjerve E, Tekleghiorghis T, Woldehiwet Z, Prevalence of antibodies to Brucella spp. and risk factors related to high-risk occupational groups in Eritrea. Epidemiol Infect. 2002;129: 85–91. 12211600
22. Kunda J, Fitzpatrick J, Kazwala R, French NP, Shirima G, Macmillan A, et al. Health-seeking behaviour of human brucellosis cases in rural Tanzania. BMC Public Health. 2007;7: 315. doi: 10.1186/1471-2458-7-315 17980046
23. Pappas G, Papadimitriou P, Akritidis N, Christou L, Tsianos EV, The new global map of human brucellosis. Lancet Infect Dis. 2006;6: 91–99. doi: 10.1016/S1473-3099(06)70382-6 16439329
24. Diaz R, Moriyón I, Young EJ, Corbel MJ, Laboratory techniques in the diagnosis of human brucellosis. In: Brucellosis. 1989. pp. 73–83.
25. Díaz R, Casanova A, Ariza J, Moriyón I, The Rose Bengal Test in human brucellosis: a neglected test for the diagnosis of a neglected disease. PLoS Negl Trop Dis. 2011;5: e950. doi: 10.1371/journal.pntd.0000950 21526218
26. Ariza J, Pellicer T, Pallares R, Foz A, Gudiol F, Specific antibody profile in human brucellosis. Clin Infect Dis. 1992;14: 131–140. 1571417
27. Gazapo E, Gonzalez Lahoz J, Subiza JL, Baquero M, Gil J, la Concha de EG, Changes in IgM and IgG antibody concentrations in brucellosis over time: importance for diagnosis and follow-up. J Infect Dis. 1989;159: 219–225. 2915152
28. Wilson MM, Merrifield EVO, The antiglobulin (Coombs) test in brucellosis. Lancet. 1951;2: 913–914. 14881511
29. Smits HL, Basahi MA, Diaz R, Marrodan T, Douglas JT, Rocha A, et al. Development and evaluation of a rapid dipstick assay for serodiagnosis of acute human brucellosis. J Clin Microbiol. 1999;37: 4179–4182. 10565959
30. Smits HL, Abdoel TH, Solera J, Clavijo E, Díaz R, Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol. 2003;10: 1141–1146. doi: 10.1128/CDLI.10.6.1141-1146.2003 14607880
31. Araj GF, Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36Suppl 1: S12–7.
32. Al-Dahouk S, Tomaso H, Nöckler K, Neubauer H, Frangoulidis D, Laboratory-based diagnosis of brucellosis—a review of the literature. Part II: serological tests for brucellosis. Clin Lab. 2003;49: 577–589. 14651329
33. Young EJ, Serologic diagnosis of human brucellosis: analysis of 214 cases by agglutination tests and review of the literature. Rev Infect Dis. 1991;13: 359–372. 1866536
34. Dean AS, Crump L, Greter H, Schelling E, Zinsstag J, Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis. 2012;6: e1865. doi: 10.1371/journal.pntd.0001865 23145195
35. de Clare Bronsvoort BM, Thumbi SM, Poole EJ, Kiara H, Auguet OT, Handel IG, et al. Design and descriptive epidemiology of the Infectious Diseases of East African Livestock (IDEAL) project, a longitudinal calf cohort study in western Kenya. BMC Vet Res. 2013;9: 171. doi: 10.1186/1746-6148-9-171 24000820
36. Spink WW, The natural course of brucellosis. The nature of brucellosis. The University of Minnesota Press; 1956. pp. 145–170.
37. OIE. Bovine Brucellosis. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. 2009. pp. 1–35.
38. Blasco JM, Garin-Bastuji B, Marin CM, Gerbier G, Fanlo J, Jiménez de Bagués MP, et al. Efficacy of different Rose Bengal and complement fixation antigens for the diagnosis of Brucella melitensis infection in sheep and goats. Vet Rec. 1994;134: 415–420. 8036772
39. Renoux G, Plommet M, Philippon A, Microreactions d'agglutination et de fixation du complement pour le diagnostic des brucellosis. Ann Rech Vet. 1971;2: 263–269.
40. Beaton CP, Forsyth JR, A micromethod for agglutination and antiglobulin tests for antibody to Brucella abortus. J Biol Stand. 1984;12: 271–275. 6434543
41. Harrell FE, Regression modeling strategies, with applications to linear models, survival analysis and logistic regression. Springer; 2001. pp. 1–582.
42. Diaz R, Ariza J, Alberola I, Casanova A, Rubio MF, Secondary serological response of patients with chronic hepatosplenic suppurative brucellosis. Clin Vaccine Immunol. 2006;13: 1190–1196. doi: 10.1128/CVI.00086-06 16943345
43. Woods CR, False-Positive Results for Immunoglobulin M Serologic Results: Explanations and Examples. J Pediatric Infect Dis Soc. 2013;2: 87–90. doi: 10.1093/jpids/pis133 26619450
44. Swai ES, Schoonman L, Human brucellosis: seroprevalence and risk factors related to high risk occupational groups in Tanga Municipality, Tanzania. Zoonoses Public Health. 2009;56: 183–187. doi: 10.1111/j.1863-2378.2008.01175.x 18811674
45. Goldstein BP, Resistance to rifampicin: a review. J Antibiot. 2014;67: 625–630. doi: 10.1038/ja.2014.107 25118103
46. Brink M. Brucellosis in Kenya: Epidemiology and Human Burden of a Neglected Zoonotic Disease. MSc Thesis, University of Uppsala. 2013.
47. Osoro EM, Munyua P, Omulo S, Ogola E, Ade F, Mbatha P, et al. Strong Association Between Human and Animal Brucella Seropositivity in a Linked Study in Kenya, 2012–2013. Am J Trop Med Hyg. 2015;93: 224–231. doi: 10.4269/ajtmh.15-0113 26101275
48. Ducrotoy MJ, Conde-Álvarez R, Blasco JM, Moriyón I, A review of the basis of the immunological diagnosis of ruminant brucellosis. Vet Immunol Immunopathol. 2016;171: 81–102. doi: 10.1016/j.vetimm.2016.02.002 26964721
49. Wattam AR, Inzana TJ, Williams KP, Mane SP, Shukla M, Almeida NF, et al. Comparative genomics of early-diverging Brucella strains reveals a novel lipopolysaccharide biosynthesis pathway. MBio. 2012;3: e00246–11.
50. Chipwaza B, Mhamphi GG, Ngatunga SD, Selemani M, Amuri M, Mugasa JP, et al. Prevalence of bacterial febrile illnesses in children in Kilosa district, Tanzania. PLoS Negl Trop Dis. 2015;9: e0003750. doi: 10.1371/journal.pntd.0003750 25955522
51. Huddleson IF, Laboratory diagnosis of brucellosis. Brucellosis in man and animals. The Commonwealth Fund; 1943. pp. 214–237.
52. John K, Kazwala R, Mfinanga GS, Knowledge of causes, clinical features and diagnosis of common zoonoses among medical practitioners in Tanzania. BMC Infect Dis. 2008;8: 162. doi: 10.1186/1471-2334-8-162 19046464
53. Zhang HL, Mnzava KW, Mitchell ST, Melubo ML, Kibona TJ, Cleaveland S, et al. Mixed Methods Survey of Zoonotic Disease Awareness and Practice among Animal and Human Healthcare Providers in Moshi, Tanzania. PLoS Negl Trop Dis. 2016;10:
54. D'Acremont V, Kilowoko M, Kyungu E, Philipina S, Sangu W, Kahama-Maro J, et al. Beyond malaria—causes of fever in outpatient Tanzanian children. N Engl J Med. 2014;370: 809–817. doi: 10.1056/NEJMoa1214482 24571753
55. Mantur BG, Biradar MS, Bidri RC, Mulimani MS, Veerappa Kariholu P, et al. Protean clinical manifestations and diagnostic challenges of human brucellosis in adults: 16 years' experience in an endemic area. J Med Microbiol. 2006;55: 897–903. doi: 10.1099/jmm.0.46097-0 16772417
56. Oomen LJ, Waghela S, The rose bengal plate test in human brucellosis. Trop Geogr Med. 1974;26: 300–302. 4439467
57. Mantur BG, Amarnath SK, Patil GA, Desai AS, Clinical utility of a quantitative Rose Bengal slide agglutination test in the diagnosis of human brucellosis in an endemic region. Clin Lab. 2014;60: 533–541. 24779287
58. Maichomo MW, McDermott JJ, Arimi SM, Gathura PB, Assessment of the Rose-Bengal plate test for the diagnosis of human brucellosis in health facilities in Narok district, Kenya. East Afr Med J. 1998;75: 219–222. 9745838
59. Mizanbayeva S, Smits HL, Zhalilova K, Abdoel TH, Kozakov S, Ospanov KS, et al. The evaluation of a user-friendly lateral flow assay for the serodiagnosis of human brucellosis in Kazakhstan. Diagn Microbiol Infect Dis. 2009;65: 14–20. doi: 10.1016/j.diagmicrobio.2009.05.002 19679230
60. Roushan MRH, Amin MJS, Abdoel TH, Smits HL, Application of a user-friendly Brucella-specific IgM and IgG antibody assay for the rapid confirmation of Rose Bengal-positive patients in a hospital in Iran. Trans R Soc Trop Med Hyg. 2005;99: 744–750. doi: 10.1016/j.trstmh.2005.02.009 16095642
61. Wardrop NA, Thomas LF, Cook EAJ, de Glanville WA, Atkinson PM, Wamae CN, et al. The Sero-epidemiology of Coxiella burnetii in Humans and Cattle, Western Kenya: Evidence from a Cross-Sectional Study. PLoS Negl Trop Dis. 2016;10: e0005032. doi: 10.1371/journal.pntd.0005032 27716804
62. Knobel DL, Maina AN, Cutler SJ, Ogola E, Feikin DR, Junghae M, et al. Coxiella burnetii in humans, domestic ruminants, and ticks in rural western Kenya. Am J Trop Med Hyg. 2013;88: 513–518. doi: 10.4269/ajtmh.12-0169 23382156
63. Cook EAJ, de Glanville WA, Thomas LF, Kariuki S, Bronsvoort BM de C, Fèvre EM, Risk factors for leptospirosis seropositivity in slaughterhouse workers in western Kenya. Occup Environ Med. 2016:
64. Maina AN, Knobel DL, Jiang J, Halliday J, Feikin DR, Cleaveland S, et al. Rickettsia felis infection in febrile patients, western Kenya, 2007–2010. Emerging Infect Dis. 2012;18: 328–331. doi: 10.3201/eid1802.111372 22304807
65. Mease LE, Coldren RL, Musila LA, Prosser T, Ogolla F, Ofula VO, et al. Seroprevalence and distribution of arboviral infections among rural Kenyan adults: a cross-sectional study. Virol J. 2011;8: 371. doi: 10.1186/1743-422X-8-371 21794131
66. Bajani MD, Ashford DA, Bragg SL, Woods CW, Aye T, Spiegel RA, et al. Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis. J Clin Microbiol. 2003;41: 803–809. doi: 10.1128/JCM.41.2.803-809.2003 12574287
67. Picardeau M, Bertherat E, Jancloes M, Skouloudis AN, Durski K, Hartskeerl RA, Rapid tests for diagnosis of leptospirosis: current tools and emerging technologies. Diagn Microbiol Infect Dis. 2014;78: 1–8. doi: 10.1016/j.diagmicrobio.2013.09.012 24207075